Literature DB >> 8618896

Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region.

I Park1, J Chung, C T Walsh, Y Yun, J L Strominger, J Shin.   

Abstract

A previously undescribed 62-kDa protein (p62) that does not contain phosphotyrosine but, nevertheless, binds specifically to the isolated src homology 2 (SH2) domain of p56lck has been identified. The additional presence of the unique N-terminal region of p56lck prevents p62 binding to the SH2 domain. However, phosphorylation at Ser-59 (or alternatively, its mutation to Glu) reverses the inhibition and allows interaction of the p56lck SH2 domain with p62. Moreover, p62 is associated with a serine/threonine kinase activity and also binds to ras GTPase-activating protein, a negative regulator of the ras signaling pathway. Thus, phosphotyrosine-independent binding of p62 to the p56lck SH2 domain appears to provide an alternative pathway for p56lck signaling that is regulated by Ser-59 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618896      PMCID: PMC40352          DOI: 10.1073/pnas.92.26.12338

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62.

Authors:  G Wong; O Müller; R Clark; L Conroy; M F Moran; P Polakis; F McCormick
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

2.  A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand.

Authors:  S N Malek; S Desiderio
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

Review 3.  The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction.

Authors:  A C Chan; D M Desai; A Weiss
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.

Authors:  G Payne; S E Shoelson; G D Gish; T Pawson; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

5.  Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain.

Authors:  I Joung; T Kim; L A Stolz; G Payne; D G Winkler; C T Walsh; J L Strominger; J Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

6.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.

Authors:  M J Eck; S E Shoelson; S C Harrison
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

7.  Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase.

Authors:  M Autero; J Saharinen; T Pessa-Morikawa; M Soula-Rothhut; C Oetken; M Gassmann; M Bergman; K Alitalo; P Burn; C G Gahmberg
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  A kinase-independent function of Lck in potentiating antigen-specific T cell activation.

Authors:  H Xu; D R Littman
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

9.  Structural features of the cytoplasmic region of CD4 required for internalization.

Authors:  J Shin; C Doyle; Z Yang; D Kappes; J L Strominger
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

10.  p56lck interacts via its src homology 2 domain with the ZAP-70 kinase.

Authors:  P Duplay; M Thome; F Hervé; O Acuto
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  34 in total

1.  Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.

Authors:  C Stumptner; H Heid; A Fuchsbichler; H Hauser; H J Mischinger; K Zatloukal; H Denk
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Identification and confirmation of a module of coexpressed genes.

Authors:  H Garrett R Thompson; Joseph W Harris; Barbara J Wold; Stephen R Quake; James P Brody
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

3.  Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3-kinases: binding partners of SH3 domains?

Authors:  C P Ponting
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

Review 4.  Paget disease of bone.

Authors:  G David Roodman; Jolene J Windle
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain.

Authors:  I Joung; J L Strominger; J Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

Authors:  Kirk H M Yip; Haotian Feng; Nathan J Pavlos; Ming H Zheng; Jiake Xu
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 7.  Minireview: Deciphering the Cellular Functions of PELP1.

Authors:  Preethi Ravindranathan; Carol A Lange; Ganesh V Raj
Journal:  Mol Endocrinol       Date:  2015-07-09

8.  Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.

Authors:  Yifeng Du; Michael C Wooten; Marla Gearing; Marie W Wooten
Journal:  Free Radic Biol Med       Date:  2008-11-21       Impact factor: 7.376

9.  Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts.

Authors:  Dominik Filipp; Behrouz Moemeni; Alessandra Ferzoco; Kirishanthy Kathirkamathamby; Jenny Zhang; Ondrej Ballek; Dominique Davidson; André Veillette; Michael Julius
Journal:  J Biol Chem       Date:  2008-07-27       Impact factor: 5.157

10.  SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.

Authors:  Frédérick A Mallette; Viviane Calabrese; Subburaj Ilangumaran; Gerardo Ferbeyre
Journal:  Aging (Albany NY)       Date:  2010-07       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.